Skip to content

Absci Corporation ABSI Proceeds from issuance of common stock relating to employee stock plans

Proceeds from issuance of common stock relating to employee stock plans at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockPlans.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's proceeds from issuance of common stock relating to employee stock plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's proceeds from issuance of common stock relating to employee stock plans?
Absci Corporation (ABSI) reported proceeds from issuance of common stock relating to employee stock plans of $59K in Q1 2026.
How has Absci Corporation's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
Absci Corporation's proceeds from issuance of common stock relating to employee stock plans decreased by 96.9% year-over-year, from $1.91M to $59K.
What is the long-term trend for Absci Corporation's proceeds from issuance of common stock relating to employee stock plans?
Over 2 years (2023 to 2025), Absci Corporation's proceeds from issuance of common stock relating to employee stock plans has grown at a 96.0% compound annual growth rate (CAGR), from $862K to $3.31M.